World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
42573
World Ranking
12455
National Ranking
1169

Overview

Andrew R. Green is affiliated with the University of Nottingham in the United Kingdom. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine. The subfields of study related to their work include Oncology, Cancer Research, Molecular Biology, Genetics, and Radiology, Nuclear Medicine and Imaging.

Their publication record reflects an emphasis on breast cancer, cancer genomics, and molecular pathways involved in cancer progression. Main topics covered in their research include Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, HER2/EGFR in Cancer Research, Cancer-related Molecular Pathways, Epigenetics and DNA Methylation, and DNA Repair Mechanisms.

Frequent co-authors collaborating with Andrew R. Green include:

  • Emad A. Rakha
  • Michael S. Toss
  • Ian O. Ellis
  • Nigel P. Mongan
  • Mansour Alsaleem

Publication venues with multiple articles from Andrew R. Green demonstrate a focus on oncology and cancer research disciplines. These venues are:

  • The Lancet
  • Breast Cancer Research and Treatment
  • Cancers
  • Histopathology
  • Cancer Research

Recent papers authored or co-authored by Andrew R. Green include:

  • "Human monkeypox - After 40 years, an unintended consequence of smallpox eradication" (2020) published in Vaccine
  • "IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis" (2020) published in Cancer Cell
  • "Breast tumor microenvironment structures are associated with genomic features and clinical outcome" (2022) published in Nature Genetics
  • "Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer" (2020) published in British Journal of Cancer
  • "Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival" (2020) published in Breast Cancer Research and Treatment

Best Publications

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

    Sahar M.A. Mahmoud;Emma Claire Paish;Desmond G. Powe;R. Douglas Macmillan

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

    Cherie Blenkiron;Leonard D Goldstein;Natalie P Thorne;Inmaculada Spiteri

  • Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

    Jack Cuzick;Mitch Dowsett;Silvia Pineda;Christopher Wale

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

    Somaia E. Elsheikh;Andrew R. Green;Emad A. Rakha;Des G. Powe

  • Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.

    Desmond G. Powe;Melanie J. Voss;Kurt S. Zänker;Hany O. Habashy

  • The shaping and functional consequences of the microRNA landscape in breast cancer

    Heidi Dvinge;Anna Git;Stefan Gräf;Stefan Gräf;Mali Salmon-Divon;Mali Salmon-Divon

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

    E A Rakha;T C Putti;D M Abd El-Rehim;C Paish

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

    Suet F Chin;Andrew E Teschendorff;John C Marioni;Yanzhong Wang

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

    Emad A Rakha;Richard W G Boyce;Dalia Abd El-Rehim;Thomas Kurien

  • BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

    S.-J. Dawson;N. Makretsov;F. M. Blows;K. E. Driver

  • FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

    Somaia Elbauomy Elsheikh;Andrew R Green;Maryou B K Lambros;Nicholas C Turner

  • Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.

    Oscar M. Rueda;Stephen John Sammut;José A. Seoane;Suet-Feung Chin

  • A gene-expression signature to predict survival in breast cancer across independent data sets

    A Naderi;A E Teschendorff;N I Barbosa-Morais;N I Barbosa-Morais;Sarah Pinder

  • The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

    S. M. A. Mahmoud;A. H. S. Lee;E. C. Paish;R. D. Macmillan

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Emad A. Rakha
Emad A. Rakha University of Nottingham
Carlos Caldas
Carlos Caldas University of Cambridge
Ritu Aneja
Ritu Aneja University of Alabama at Birmingham
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Jonathan M. Garibaldi
Jonathan M. Garibaldi University of Nottingham
John F.R. Robertson
John F.R. Robertson University of Nottingham
Julia Margaret Wendy Gee
Julia Margaret Wendy Gee Cardiff University
Sarah E Pinder
Sarah E Pinder King's College London
Justin Stebbing
Justin Stebbing Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up diverse career opportunities beyond traditional clinical roles. Many students are exploring online degrees to enter specialized and in-demand healthcare fields. These online pathways provide flexibility, affordability, and a fast track to rewarding careers.

For those interested in mental health, online psych np programs offer advanced nursing education focused on psychiatric care. Graduates can pursue certification and make a significant impact in mental health services.

If managing healthcare systems appeals to you, consider earning a bachelors in health administration. This degree is an ideal starting point for a non-clinical healthcare career and is available through accredited online programs.

For those aiming higher, the cheapest online mha programs make it feasible to earn a master’s in healthcare administration and qualify for top-level management roles.

Nurses looking to advance further can benefit from the cheapest bsn to dnp programs, allowing for a direct path to a terminal practice degree online and greater leadership or clinical authority.

Best Scientists Citing Andrew R. Green

Trending Scientists

Recently Published Articles